首页> 外文期刊>Carcinogenesis >Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene
【24h】

Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene

机译:免疫抑制的肾移植患者的皮肤癌危险因素分析显示p53基因的UV特异性串联CC至TT突变水平高

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Immunosuppressed renal transplant recipients (RTRs) are predisposed to non-melanoma skin cancers (NMSCs), predominantly squamous cell carcinomas (SCCs). We have analyzed skin lesions from RTRs with aggressive tumors for p53 gene modifications, the presence of Human Papillomas Virus (HPV) DNA in relation to the p53 codon 72 genotype and polymorphisms of the XPD repair gene. We detected 24 p53 mutations in 15/25 (60%) NMSCs, 1 deletion and 23 base substitutions, the majority (78%) being UV-specific C to T transitions at bipyrimidine sites. Importantly, 35% (6/17) are tandem mutations, including 4 UV signature CC to TT transitions possibly linked to modulated DNA repair caused by the immunosuppressive drug cyclosporin A (CsA). We found 8 p53 mutations in 7/17 (41%) precancerous actinic keratosis (AK), suggesting that p53 mutations are early events in RTR skin carcinogenesis. Immunohistochemical analysis shows a good correlation between p53 accumulation and mutations. HPV DNA was detected in 78% of skin lesions (60% Basal Cell Carcinomas, 82%AK and 79% SCCs). Thus, immunosuppression has increased the risk of infections by HPVs, predominantly epidermodysplasia verruciformis, speculated to play a role in skin cancer development. No association is found between HPV status and p53 mutation. Moreover, p53 codon 72 or frequencies of three XPD genotypes of RTRs are comparable with control populations. The p53 mutation spectrum, presenting a high level of CC to TT mutations, shows that the UV component of sunlight is the major risk factor and modulated DNA repair by immunosuppressive drug treatment may be significant in the skin carcinogenesis of RTRs.
机译:免疫抑制的肾移植受者(RTR)易患非黑素瘤皮肤癌(NMSC),主要是鳞状细胞癌(SCC)。我们已经分析了具有侵袭性肿瘤的RTRs的皮肤病变,以进行p53基因修饰,与p53密码子72基因型相关的人乳头状瘤病毒(HPV)DNA的存在以及XPD修复基因的多态性。我们在15/25(60%)NMSC中检测到24个p53突变,1个缺失和23个碱基取代,其中大多数(78%)是联嘧啶位点的UV特异的C到T跃迁。重要的是,35%(6/17)是串联突变,包括4个紫外线特征CC到TT的转变,可能与免疫抑制药物环孢菌素A(CsA)引起的DNA修复调控有关。我们在7/17(41%)的癌前性光化性角化病(AK)中发现8个p53突变,这表明p53突变是RTR皮肤癌变的早期事件。免疫组织化学分析显示p53积累与突变之间有良好的相关性。在78%的皮肤病变(60%的基底细胞癌,82%的AK和79%的SCC)中检测到HPV DNA。因此,免疫抑制增加了被认为在皮肤癌的发展中起作用的HPV(主要是疣状表皮发育不良)感染的风险。在HPV状态和p53突变之间未发现关联。此外,p53密码子72或RTR的三种XPD基因型的频率与对照人群相当。 p53突变光谱显示出高水平的CC到TT突变,表明日光的紫外线成分是主要危险因素,通过免疫抑制药物治疗调节的DNA修复在RTR的皮肤癌变中可能很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号